Stocks-1873.HK-Viva Biotech Holdings

1873.HK Viva Biotech Holdings

1.8173 0.0300 (1.68%)
Prices By Xignite, in HKD Market Closed
Invest
Invest

Overview

Prev Close1.8173
Day's Range 1.7973 - 1.8572
52 Week Range 1.1583 - 3.8500
Average Volume (3M)15.66M
1-Year Return-50.88%
Beta-0.0124
Market Cap3.49B
P/E Ratio27.74
Revenue2.64B
EPS0.0656
Dividend (Yield)0 (0%)
1 Day 1 Week 1 Month 3 Months 6 Months 1 Year 3 Years Max
Chart times in UTC
Industry Biotechnology
CEO Chen Mao
Employees 2,127

FINANCIAL SUMMARY

For the fiscal year ended 31/12/2021: Viva Biotech Holdings's revenues increased by 223.80% and amounted to 2.54B. Net income increased by 185.09% to 362.24M. Net assets increased by 7.47% to 4.79B and EPS increased from -0.28 to 0.10.
1873.HK's Investor Relations
Income StatementBalance SheetCash Flow Statement
Gross Margin
31.09%
Net Profit Margin
20.89%
Operating Margin
8.87%
Return On Investment
12.74%
2018
2019
2020
2021
Total Revenue
248.77M
366.32M
783.17M
2.54B
Gross Profit
124.91M
176.75M
342.58M
784.57M
Operating Income
60.06M
61.6M
126.46M
285.52M
Net Income
107.25M
301.48M
-425.73M
362.24M